Skip to main content
FinSpry Logo
FinSpry
RPRX logo
RPRX
(NASDAQ)
Royalty Pharma plc
$53.57-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Royalty Pharma plc (RPRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Royalty Pharma plc stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(8 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$59.43
↑ 10.94% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest RPRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Geoff Meacham
Citi
BuyMaintains
$66.00
Michael Nedelcovych
TD Cowen
BuyMaintains
$50.00
Asad Haider
Goldman Sachs
BuyReiterates
$51.00 → $59.00
Jason Gerberry
BofA Securities
BuyMaintains
$54.00 → $62.00
Chris Schott
JP Morgan
BuyMaintains
$50.00 → $58.00
Terence Flynn
Morgan Stanley
BuyMaintains
$63.00 → $64.00
Ashwani Verma
UBS
Strong BuyMaintains
$51.00 → $57.00
Terence Flynn
Morgan Stanley
BuyMaintains
$61.00 → $63.00

Frequently Asked Questions

What is the analyst consensus rating for RPRX?

The analyst consensus rating for RPRX is "Buy" based on 7 analyst recommendations.

What is the average price target for RPRX?

The average 12-month price target for RPRX is $59.43, representing an upside of 10.9% from the current price of $53.57.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.